The Wall Street Journal

How a surfie who never finished uni became a biotech billionaire

How a surfie who never finished uni became a biotech billionaire
Bob Duggan is now said to be worth $25.6 billion. (Image: Summit Therapeutics)
The Wall Street Journal
By David WainerThere is a myth that making money in biotechnology stocks requires an advanced degree. But Bob Duggan, an avid surfie who never graduated from university, has proven that notion wrong. Twice.Duggan’s latest investment, Summit Therapeutics, has become one of the industry’s greatest bets in recent years. The stock is up more than 1,000% in the past 12 months thanks to data from a late-stage trial that showed that its drug, Ivonescimab, beat Merck’s blockbuster cancer drug Keytruda in patients with a form of l...

More Health

The NZ company 'democratising hearing health'
Health On The Up

The NZ company 'democratising hearing health'

Can hearing aids be made both affordable and desirable?

Pattrick Smellie 09 May 2025
Health NZ weighs AI tools as doctors see productivity gains
Health

Health NZ weighs AI tools as doctors see productivity gains

Health NZ is yet to endorse any AI tools for staff use.

John Anthony 07 May 2025
Radius buys care home off Arvida
Property

Radius buys care home off Arvida

Radius Care will have another 109 beds in Christchurch.

Gregor Thompson 30 Apr 2025
Why this tech firm sees a Trump tariff opportunity
Markets The small cap wrap

Why this tech firm sees a Trump tariff opportunity

Plus IkeGPS' wins in the US, Trade Window targets trade war, TruScreen, and more.